In colorectal carcinoma, tumoral tissues infiltrate with variousimmune/inflammatory cells along their invasive margins and the increased S100A8/A9expression in these immune cells infiltrating the tumor has recently been demonstrated.We examined S100A8/A9 as a potential therapeutic target in the treatment of colorectalcarcinoma. This evidence concerns the gene IGKV1D-22 and colorectal carcinoma.